PrEP4Love: The Role of Messaging and Prevention Advocacy in PrEP Attitudes, Perceptions, and Uptake Among YMSM and Transgender Women.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
15 04 2020
Historique:
pubmed: 16 1 2020
medline: 30 10 2020
entrez: 16 1 2020
Statut: ppublish

Résumé

Despite high efficacy, use of pre-exposure prophylaxis (PrEP) remains low among young men who have sex with men (MSM) and transgender women (TW), primarily because of barriers such as stigma and resource awareness. We evaluated a social marketing campaign known as PrEP4Love that works to eliminate PrEP stigma; and awareness gaps through targeted advertising. Chicago, Illinois. Participants were enrolled within a cohort study of young MSM and TW (RADAR). Data were collected between June 2017 and April 2018 from HIV-negative individuals attending a follow-up visit. Surveys assessed demographics, PrEP attitudes and perceptions, and PrEP4Love campaign awareness. Associations between PrEP4Love awareness and PrEP perceptions, uptake, and behaviors were assessed using multiple logistic regression controlling for age, race/ethnicity, gender, sexual identity, and ever having used PrEP. Of 700 participants, the majority (75.9%) indicated seeing PrEP4Love ads in Chicago. Those who had seen ads were more likely to be out to their providers (odds ratio = 1.95; 95% confidence interval: 1.17 to 3.23) than those who had not, and those who had conversations were significantly more likely to have initiated the conversation themselves. Individuals who had seen ads were more likely to have taken PrEP in the last 6 months (odds ratio = 1.87; 95% confidence interval: 1.15 to 3.16) and more likely to believe their friends and the general public approved of and used PrEP. Social marketing campaigns are promising interventions that have the potential to alleviate barriers to HIV prevention, particularly among MSM and TW. Future research should evaluate the impact of these initiatives at multiple time points.

Sections du résumé

BACKGROUND
Despite high efficacy, use of pre-exposure prophylaxis (PrEP) remains low among young men who have sex with men (MSM) and transgender women (TW), primarily because of barriers such as stigma and resource awareness. We evaluated a social marketing campaign known as PrEP4Love that works to eliminate PrEP stigma; and awareness gaps through targeted advertising.
SETTING
Chicago, Illinois.
METHODS
Participants were enrolled within a cohort study of young MSM and TW (RADAR). Data were collected between June 2017 and April 2018 from HIV-negative individuals attending a follow-up visit. Surveys assessed demographics, PrEP attitudes and perceptions, and PrEP4Love campaign awareness. Associations between PrEP4Love awareness and PrEP perceptions, uptake, and behaviors were assessed using multiple logistic regression controlling for age, race/ethnicity, gender, sexual identity, and ever having used PrEP.
RESULTS
Of 700 participants, the majority (75.9%) indicated seeing PrEP4Love ads in Chicago. Those who had seen ads were more likely to be out to their providers (odds ratio = 1.95; 95% confidence interval: 1.17 to 3.23) than those who had not, and those who had conversations were significantly more likely to have initiated the conversation themselves. Individuals who had seen ads were more likely to have taken PrEP in the last 6 months (odds ratio = 1.87; 95% confidence interval: 1.15 to 3.16) and more likely to believe their friends and the general public approved of and used PrEP.
CONCLUSION
Social marketing campaigns are promising interventions that have the potential to alleviate barriers to HIV prevention, particularly among MSM and TW. Future research should evaluate the impact of these initiatives at multiple time points.

Identifiants

pubmed: 31939870
doi: 10.1097/QAI.0000000000002297
pmc: PMC7083076
mid: NIHMS1549613
pii: 00126334-202004150-00002
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

450-456

Subventions

Organisme : NIAID NIH HHS
ID : P30 AI117943
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA036939
Pays : United States

Références

Prev Sci. 2017 Jul;18(5):505-516
pubmed: 28101813
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
Clin Trials. 2018 Feb;15(1):44-52
pubmed: 28862483
AIDS Behav. 2019 Jun;23(6):1452-1459
pubmed: 30242531
Ann Intern Med. 1998 Jul 15;129(2):128-32
pubmed: 9669972
JAMA Intern Med. 2016 Jan;176(1):136-8
pubmed: 26571368
AIDS Care. 2017 Nov;29(11):1351-1358
pubmed: 28286983
JMIR Public Health Surveill. 2016 May 30;2(1):e27
pubmed: 27244774
Public Health Res Pract. 2015 Mar 30;25(2):e2521517
pubmed: 25848735
PLoS One. 2017 Feb 21;12(2):e0172354
pubmed: 28222118
AIDS Behav. 2017 May;21(5):1288-1298
pubmed: 27401537
Am J Public Health. 1991 Feb;81(2):168-71
pubmed: 1990853
AIDS Patient Care STDS. 2015 Aug;29(8):423-9
pubmed: 26083143
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):547-555
pubmed: 27454250
Psychiatr Serv. 2017 Dec 1;68(12):1299-1302
pubmed: 28945185
AIDS Behav. 2019 Oct;23(10):2749-2760
pubmed: 31228025
AIDS Behav. 2013 Jul;17(6):2173-9
pubmed: 23128980
Glob Public Health. 2016 Aug-Sep;11(7-8):1060-75
pubmed: 26963756
MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1291-5
pubmed: 26606148
PLoS Med. 2006 Mar;3(3):e145
pubmed: 16563041
Psychol Methods. 2000 Mar;5(1):44-63
pubmed: 10937322
Ann Epidemiol. 2017 Mar;27(3):176-180
pubmed: 28003117
AIDS Behav. 2017 May;21(5):1236-1246
pubmed: 28108878
AIDS Behav. 2018 Sep;22(9):3044-3056
pubmed: 29789985
Am J Public Health. 2010 Dec;100(12):2426-32
pubmed: 20966378
AIDS Behav. 2016 Nov;20(11):2772-2781
pubmed: 26902295
Int J Environ Res Public Health. 2019 May 30;16(11):
pubmed: 31151275
J Int AIDS Soc. 2017 Aug 2;20(1):21899
pubmed: 28782336
Prev Sci. 2019 Oct;20(7):1089-1097
pubmed: 30712223
AIDS Educ Prev. 2013 Aug;25(4):327-35
pubmed: 23837810
AIDS Educ Prev. 2015 Apr;27(2):112-25
pubmed: 25915697
Nat Hum Behav. 2017 Nov;1(11):797-802
pubmed: 31024121
Sex Transm Dis. 2012 Aug;39(8):598-604
pubmed: 22801341
Am J Health Promot. 2018 Jun;32(5):1248-1256
pubmed: 28759999
AIDS Behav. 2018 Apr;22(4):1139-1149
pubmed: 29143163
Lancet Infect Dis. 2014 Jun;14(6):468-75
pubmed: 24613084
AIDS Educ Prev. 2015 Jun;27(3):275-87
pubmed: 26010317
JAMA Oncol. 2016 Nov 1;2(11):1397-1398
pubmed: 27532895
Clin Infect Dis. 2016 Sep 1;63(5):672-7
pubmed: 27282710
Lancet HIV. 2015 Dec;2(12):e512-9
pubmed: 26614965

Auteurs

Gregory Phillips (G)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Evaluation, Data Integration, and Technical Assistance Program, Northwestern University, Chicago, IL.

Anand B Raman (AB)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Evaluation, Data Integration, and Technical Assistance Program, Northwestern University, Chicago, IL.

Dylan Felt (D)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Evaluation, Data Integration, and Technical Assistance Program, Northwestern University, Chicago, IL.

David J McCuskey (DJ)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Evaluation, Data Integration, and Technical Assistance Program, Northwestern University, Chicago, IL.

Christina S Hayford (CS)

Third Coast Center for AIDS Research, Chicago, IL; and.

Jim Pickett (J)

AIDS Foundation of Chicago, Chicago, IL.

Peter T Lindeman (PT)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Evaluation, Data Integration, and Technical Assistance Program, Northwestern University, Chicago, IL.

Brian Mustanski (B)

Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH